मैट्रिक्स
 
 
सम्राट फार्माकेम > कंपनी इतिहास > Pharmaceuticals > कंपनी इतिहास का सम्राट फार्माकेम - बीएसई: 530125, NSE: N.A

सम्राट फार्माकेम

बीएसई: 530125  |  NSE: N.A  |  ISIN: INE103E01016  |  Pharmaceuticals

कंपनी इतिहास - सम्राट फार्माकेम
 Samrat Phannachem Limited was incorporated as Private Limited Company
 on 16th June 1992, under the Companies Act, 1956 in the State of
 Gujarat and subsequently converted into a public limited company on
 24th July, 1992. Samrat Pharmachem Limited is going for an expansion
 of its facilities for manufacture of Bulk Drugs at Ankleshwar,
 Gujarat, it has taken over the unit comprising of land & building,
 machinery and other assets and liabilities costing Rs.30.64 lacs from
 M/s. Lub-chem, Bombay a partnerahip firm, promoted by the same
 management at book value
 on 1st April 1993.
 
 THE MAIN OBJECTS OF THE COMPANY
 
 The main objects of the company as set out in the Memorandum &
 Articles of Association are as follows:
 
 To carry on the business as manufacturers, manufacturer's
 representatives, dealers, traders, factors, agents, suppliers,
 stockists, packers, distributors, exporters, and importers of all
 kinds, types, nature and description of medicine, drugs, drug
 intermediates, pharmaceuticals, mixtures, powders, tablets, capsules,
 injunctions, compounds, formulations, nutrients, health products,
 creams, lotions, syrups, tonics, biological and biochemical products,
 pills, mother tinctures, triturations, glucose, nourishment foods,
 ointment, surgical dressings, water for injections and medical
 preparations, required for or used in allopathic ayurvedic, unani,
 homeopathic and nature cure
 treatments for prevention or prophylactic cure for human beings,
 animals, insects and birds.
 
 SUBSIDIARIES
 
 The company does not have any subsidiary at present.
 
 PRESENT BUSINESS OF THE COMPANY
 
 The Company is currently engaged in the manufacture and export of
 pharmaceutical bulk drugs, namely Potassium Iodide IP, Potassium
 Iodate IP, Iodine IP and Ferrous Fumerate IP.  The Company has
 achieved a turnover of Rs.153.51 lacs and cash profit of Rs 8.79 lacs
 during the five month period ended 31st August, 1994.
 
 The Company exports its goods to Singapore, Japan, U.S.A. and other
 countries.  For the year ended March 1994 the Company has achieved
 direct and indirect exports worth Rs.35.59 lacs. For period from
 April 1994 to August 1994, it has achieved direct exports worth
 Rs.12.24 lacs & it has exported goods worth Rs.25.15 lacs through
 Export House & Merchant Exporters.
 
 
 2008
 
 -E-mail ID for Investors Complaints:samrat@bom4.vsnl.net.in
 
 2013
 -Samrat Pharmachem Ltd has informed that Companys Corporate Office
 Address effective from April 01, 2013 as under :701 / 702, Business
 Square, M. A. Road, Andheri (West), Mumbai - 400058. Tel: (91-22)
 26701050 / 1 / 2 Fax: (91-22) 26701053 Email: samrat@bom4.vsnl.net.in
 Web: www.samratpharmachem.com
 
 
 
 
स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • MARKET CUES : FIIs ने कैश में `558 Cr की बिकवाली की
  • MARKET CUES : DIIs ने कैश में `985 Cr की बिकवाली की
  • MARKET CUES : FIIs ने F&O में `1528 Cr की खरीदारी की
  • MARKET CUES : इंडेक्स फ्यूचर्स में `1328 Cr की खरीदारी की
  • MARKET CUES : इंडेक्स ऑप्शंस में `198 Cr की खरीदारी की
  • MARKET CUES : स्टॉक फ्यूचर्स में `318 Cr की खरीदारी की
  • MS ON ASIAN PAINTS : Equalweight रेटिंग, लक्ष्य `1820/Sh
  • HSBC ON BAJAJ FINANCE : BUY रेटिंग, लक्ष्य `5100/Sh
  • MS ON BAJAJ FINANCE : Equalweight रेटिंग, लक्ष्य `3700/Sh
  • JP MORGAN ON BAJAJ FINANCE : Overweight रेटिंग, लक्ष्य `4500/Sh

अभी देखें

टैक्स गुरु

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(August 06, 2018)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo

Powerful mix of both trader and investor packs with timely expert advice.

Technical

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental

For all investors looking to unearth stocks that are poised to move.